Cite
MLA Citation
D.L. Chan et al.. “Avelumab in unresectable/metastatic, progressive, grade 2–3 neuroendocrine neoplasms (NENs): Combined results from NET-001 and NET-002 trials.” European journal of cancer, vol. 169, 2022, pp. 74–81. http://access.bl.uk/ark:/81055/vdc_100156436639.0x00002b